Anatara Lifesciences Advances Trials and Raises Capital
Anatara Lifesciences Ltd (AU:ANR) has released an update. Anatara Lifesciences is advancing its Phase II trial for GaRP in treating Irritable ...
Seeking Alpha18h
Allurion Technologies Inc. (ALUR) Q3 2024 Earnings Call Transcript
More of our providers are using the Allurion Balloon in combination with GLP-1s. 33% of our patients now have previously tried an anti-obesity medication. That’s up from 25% last year. And what we’re ...
malaymail2h
Hold my Ozempic: British Vogue editor sounds alarm over comeback of ultra-thin models
LONDON, Nov 14 — The editorial director of British Vogue magazine on Wednesday said she was worried about the return of thin ...